Brief: Viva Biotech Sees HY Net Loss Of Not More Than Rmb100 Mln
Aug 12 (Reuters) - VIVA Biotech Holdings 1873.HK :
* SEES NET LOSS OF NOT MORE THAN RMB100 MILLION FOR SIX
MONTHS
* REVENUE OF GROUP IS EXPECTED TO INCREASE BY OVER 5% FOR
SIX
MONTHS
* SEES ADJUSTED NET PROFIT FOR SIX MONTHS RMB80 MILLION
* EXPECTED NET LOSS DUE TO COVID-19 LIMITING DELIVERY OF
GROUP'S
PRODUCTS AND SERVICES, AMONG OTHERS
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical